Hyperbilirubinemia following lenalidomide administration

被引：1

作者：

Azmy, Veronica ^{[1
]}

Neparidze, Natalia ^{[2
]}

机构：

[1] Yale Univ, Sch Med, New Haven, CT 06510 USA

[2] Yale Univ, Smilow Canc Hosp, Sch Med, New Haven, CT 06510 USA

来源：

CLINICAL CASE REPORTS | 2018年 / 6卷 / 05期

关键词：

chemotherapy; Gilbert's syndrome; hyperbilirubinemia; lenalidomide; multiple myeloma;

D O I：

10.1002/ccr3.1471

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Asymptomatic hyperbilirubinemia in a patient with no underlying liver disease or renal impairment while on lenalidomide therapy may be attributable to the unmasking of previously undiagnosed Gilbert's syndrome, as previously shown in the literature. The hyperbilirubinemia should resolve after discontinuation of the drug.

引用

页码：875 / 877

页数：3

共 50 条

[31] Effect of Oral administration of Cholestylamine with Phototherapy in the Treatment of Neonatal Hyperbilirubinemia • 1081
Ho O Myung
Jay G Sim
Kee Hyuck Kim
Min Hee Kim
Pediatric Research, 1998, 43 (Suppl 4) : 186 - 186
[32] Does Hyperbilirubinemia Contribute to Adverse Patient Outcomes Following Pancreatoduodenectomy?
Scott Dolejs
Ben L. Zarzaur
Nicholas J. Zyromski
Henry A. Pitt
Taylor S. Riall
Bruce L. Hall
Stephen W. Behrman
Journal of Gastrointestinal Surgery, 2017, 21 : 647 - 656
[33] Lenalidomide in multiple myeloma following stem cell transplant
不详
EJHP PRACTICE, 2010, 16 (02): : 14 - 14
[34] Lenalidomide in multiple myeloma following stem cell transplant
不详
EJHP PRACTICE, 2010, 16 (01): : 14 - 14
[35] Does Hyperbilirubinemia Contribute to Adverse Patient Outcomes Following Pancreatoduodenectomy?
Dolejs, Scott
Zarzaur, Ben L.
Zyromski, Nicholas J.
Pitt, Henry A.
Riall, Taylor S.
Hall, Bruce L.
Behrman, Stephen W.
JOURNAL OF GASTROINTESTINAL SURGERY, 2017, 21 (04) : 647 - 656
[36] A Clinical Prediction Rule for Rebound Hyperbilirubinemia Following Inpatient Phototherapy
Chang, Pearl W.
Kuzniewicz, Michael W.
McCulloch, Charles E.
Newman, Thomas B.
PEDIATRICS, 2017, 139 (03)
[37] Neonatal Hyperbilirubinemia Admissions Following Clinical Practice Guideline Implementation
Smith, Morgan
Ridgway, Austin
Mullikin, Dolores
MILITARY MEDICINE, 2024, 189 (5-6) : e1259 - e1262
[38] Does Hyperbilirubinemia Contribute to Adverse Patient Outcomes Following Pancreatoduodenectomy?
Zarzaur, Ben L.
Zyromski, Nicholas J.
Pitt, Henry
Hall, Bruce L.
Behrman, Stephen W.
Riall, Taylor
GASTROENTEROLOGY, 2016, 150 (04) : S1256 - S1256
[39] ETIOLOGY AND SIGNIFICANCE OF HYPERBILIRUBINEMIA FOLLOWING THE DISTAL SPLENORENAL SHUNT (DSRS)
VO, N
RIKKERS, LF
GASTROENTEROLOGY, 1984, 86 (05) : 1289 - 1289
[40] Prolonged Direct Hyperbilirubinemia Following Acute Hepatitis: When Not to Worry?
Zhao, Danzhu
Wu, George Y.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2024, 12 (12) : 985 - 987

← 1 2 3 4 5 →